TG THERAPEUTICS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
TG THERAPEUTICS, INC. (TGTX) had Deferred Tax Assets, Goodwill and Intangible Assets of $0 as of 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2014-03-07
- 2013-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $0.00.
- 2012-12-31: Deferred Tax Assets, Goodwill and Intangible Assets -$1.20M.
- 2011-12-31: Deferred Tax Assets, Goodwill and Intangible Assets -$2.22M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-07 |
| 2012-12-31 | -$1.20M 10-K · filed 2014-03-07 |
| 2011-12-31 | -$2.22M 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |